This suggests that a metabolic switch may operate in PCa and this has important implications for patient management, with two metabolic phenotypes that match the two morphological patterns observed in cancer tissue; well-formed and poorly formed glands that are defined respectively by sortilin and syndecan-1. The gene discussed is SDC1; the disease is posterior cortical atrophy.